Nypozi

Filgrastim-txid · Cipla USA Inc.
PRESCRIPTION ONLY (USA)

Nypozi ingredients

Active ingredientStrength
Filgrastim480 ug/480ug, 300 ug/300ug

What Nypozi is used for

Nypozi is a specialist medicine (leukocyte growth factor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Nypozi
Generic name
Filgrastim-txid
Made by
Cipla USA Inc.
Forms
Injection
Given
Intravenous, Subcutaneous
Drug class
Leukocyte Growth Factor
FDA approval
Biologic licence (BLA) BLA761126
On the US market since
2026

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Nypozi?

Nypozi (Filgrastim-txid) is a specialist medicine made by Cipla USA Inc., approved by the US FDA.

What are the ingredients of Nypozi?

Nypozi contains Filgrastim (480 ug/480ug, 300 ug/300ug).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.